Literature DB >> 16178886

High prevalence of vasomotor reflex impairment in newly diagnosed leprosy patients.

X Illarramendi1, S Bührer-Sékula, A M Sales, M I Bakker, A Oliveira, J A C Nery, L Oskam, A Wilder-Smith, E P Sampaio, E N Sarno.   

Abstract

BACKGROUND: Initial nerve damage in leprosy occurs in small myelinated and unmyelinated nerve fibers. Early detection of leprosy in the peripheral nervous system is challenging as extensive nerve damage may take place before clinical signs of leprosy become apparent. PATIENTS AND METHODS: In order to determine the prevalence of, and factors associated with, peripheral autonomic nerve dysfunction in newly diagnosed leprosy patients, 76 Brazilian patients were evaluated prior to treatment. Skin vasomotor reflex was tested by means of laser Doppler velocimetry. Blood perfusion and reflex vasoconstriction following an inspiratory gasp were registered on the second and fifth fingers.
RESULTS: Vasomotor reflex was impaired in at least one finger in 33/76 (43%) patients. The fifth fingers were more frequently impaired and suffered more frequent bilateral alterations than the second fingers. Multivariate regression analysis showed that leprosy reaction (adjusted odds ratio = 8.11, 95% confidence interval: 1.4-48.2) was associated with overall impaired vasomotor reflex (average of the four fingers). In addition, palmar erythrocyanosis and an abnormal upper limb sensory score were associated with vasomotor reflex impairment in the second fingers, whereas anti-phenolic glycolipid-I antibodies, ulnar somatic neuropathy and a low finger skin temperature were associated with impairment in the fifth fingers.
CONCLUSIONS: A high prevalence of peripheral autonomic dysfunction as measured by laser Doppler velocimetry was observed in newly diagnosed leprosy patients, which is clinically evident late in the disease. Autonomic nerve lesion was more frequent than somatic lesions and was strongly related to the immune-inflammatory reaction against M. leprae.

Entities:  

Mesh:

Year:  2005        PMID: 16178886     DOI: 10.1111/j.1365-2362.2005.01554.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

Review 1.  Infectious diseases causing autonomic dysfunction.

Authors:  Francisco Javier Carod-Artal
Journal:  Clin Auton Res       Date:  2017-07-20       Impact factor: 5.625

2.  Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial.

Authors:  Josafá G Barreto; Claudio G Salgado
Journal:  BMC Infect Dis       Date:  2010-08-10       Impact factor: 3.090

3.  Progression of leprosy neuropathy: a case series study.

Authors:  Robson T Vital; Ximena Illarramendi; Osvaldo Nascimento; Mariana A Hacker; Euzenir N Sarno; Marcia R Jardim
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

4.  Hansen's disease associated with erythromelalgia mimicking Lupus erythematosus.

Authors:  Shenoi Shrutakirthi Damodar; Prabhu Smitha; Balakrishnan Nirmal; Nayak U K Sudhir; Pai Sathish Ballambat
Journal:  Indian Dermatol Online J       Date:  2014-01

5.  Thermographic analysis and autonomic response in the hands of patients with leprosy.

Authors:  Aretusa Lopes Cavalheiro; Debora Tacon da Costa; Ana Luiza Ferro de Menezes; Janser Moura Pereira; Eliane Maria de Carvalho
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

6.  Tuberculoid leprosy: An in vivo microvascular evaluation of cutaneous lesions.

Authors:  Livia Pino; Maria das Graças Coelho de Souza; Omar Lupi; Eliete Bouskela
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

Review 7.  Treatment and Evaluation Advances in Leprosy Neuropathy.

Authors:  Gigi J Ebenezer; David M Scollard
Journal:  Neurotherapeutics       Date:  2021-11-19       Impact factor: 7.620

8.  The clinical & neurophysiological study of leprosy.

Authors:  Murat Cabalar; Vildan Yayla; Samiye Ulutas; Songul Senadim; Ayla Culha Oktar
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.